Epistatic interactions in genetic regulation of t-PA and PAI-1 levels in a Ghanaian population

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Penrod, Nadia M ^a   Poku, Kwabena A ^b   Vaughn, Douglas E ^c   Asselbergs, Folkert W ^d   Brown, Nancy J ^c   Moore, Jason H ^a   Williams, Scott M ^c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF GHANA BUSINESS SCHOOL   (Ghana)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ETHANOLAMINE KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RENIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC POLYMORPHISM; GENETIC REGULATION; GHANA; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; ANALYSIS OF VARIANCE; BLOOD; GENE EXPRESSION REGULATION; GENETICS;

ANALYSIS OF VARIANCE; EPISTASIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GHANA; HUMANS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; SEX FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79551634268     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016639     Document Type: Article

References (23)

1. Cesarman-Maus G, Hajjar KA (2005) Molecular mechanisms of fibrinolysis. Br J Haematol 129: 307-321. BJH5444 [pii]. doi: 10.1111/j.1365-2141.2005.05444.x.
2. Pretorius M, Rosenbaum D, Vaughan DE, Brown NJ (2003) Angiotensinconverting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin. Circulation 107: 579-585.
3. Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE (1998) Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 32: 965-971.
4. Brown NJ, Gainer JV, Stein CM, Vaughan DE (1999) Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension 33: 1431-1435.
5. Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, et al. (1997) Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol 17: 2082-2087.
6. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, et al. (1993) Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 87: 1969-1973.
7. Francis RB, Jr., Kawanishi D, Baruch T, Mahrer P, Rahimtoola S, et al. (1988) Impaired fibrinolysis in coronary artery disease. Am Heart J 115: 776-780. 0002-8703(88)90878-2 [pii].
8. Thogersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, et al. (1998) High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 98: 2241-2247.
9. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, et al. (1992) Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci U S A 89: 6998-7002.
10. Margaglione M, Di MG, Grandone E, Vecchione G, Celentano E, et al. (1994) Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb 14: 1741-1745.
11. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ (1993) Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 342: 1076-1079. 0140-6736(93)92062-X [pii].
12. Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, et al. (2006) The gender-specific role of polymorphisms from the fibrinolytic, reninangiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels. Thromb Haemost 96: 471-477. 06100471 [pii].
13. Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, et al. (2007) Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels. Genomics 89: 362-369. S0888-7543(06)00322-3 [pii];10.1016/j.ygeno.2006.11.004 [doi].
14. Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, et al. (2007) Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits. J Thromb Haemost 5: 313-320.
15. Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, et al. (2007) The effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context. Hum Genet 122: 275-281. 10.1007/s00439-007-0400-9 [doi].
16. Schoenhard JA, Asselbergs FW, Poku KA, Stocki SA, Gordon S, et al. (2008) Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population. Hum Genet 124: 479-488. 10.1007/s00439-008-0573-x [doi].
17. Williams SM, Stocki S, Jiang L, Brew K, Gordon S, et al. (2007) A populationbased study in Ghana to investigate inter-individual variation in plasma t-PA and PAI-1. Ethn Dis 17: 492-497.
18. Pattin KA, Moore JH (2008) Exploiting the proteome to improve the genomewide genetic analysis of epistasis in common human diseases. Hum Genet 124: 19-29. 10.1007/s00439-008-0522-8 [doi].
19. Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1: 43-6.
20. Tian Y, Jackson P, Gunter C, Wang J, Rock CO, et al. (2006) Placental thrombosis and spontaneous fetal death in mice deficient in ethanolamine kinase 2. J Biol Chem 281: 28438-28449. M605861200 [pii];10.1074/ jbc.M605861200 [doi].
21. Eriksson P, Kallin B, van 't Hooft FM, Bavenholm P, Hamsten A (1995) Allelespecific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 92: 1851-1855.
22. Festa A, D'Agostino R, Jr., Rich SS, Jenny NS, Tracy RP, et al. (2003) Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation 107: 2422-2427.
23. Moore JH, Williams SM (2005) Traversing the conceptual divide between biological and statistical epistasis: Systems biology and a more modern synthesis. BioEssays In Press.